Quratis Inc. (KOSDAQ:348080)
South Korea · Delayed Price · Currency is KRW 1,071.00
+6.00 (0.56%)
At close: Jan 23, 2026
Quratis Company Description
Quratis Inc. engages in developing vaccines in South Korea.
It is involved in developing QTP101, a vaccine for tuberculosis; QTP104, a next-generation mRNA vaccine; CPP (Cell Penetrating Peptide) Platform, a cell and bacterial penetration peptide drug delivery platform technology; and Peptide Nucleic Acid (PNA), a synthetic analogue of DNA in which the deoxyribose phosphate backbone.
The company also offers drugs contract development and manufacturing services. Quratis Inc. was incorporated in 2016 and is based in Cheongju-si, South Korea.
Quratis Inc.
| Country | South Korea |
| Founded | 2016 |
| Industry | Biological Products, Except Diagnostic Substances |
Contact Details
Address: 143 Medical Complex-gil Cheongju-si, 08375 South Korea | |
| Phone | 82 4 3904 7110 |
| Website | quratis.com |
Stock Details
| Ticker Symbol | 348080 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2836 |